Prestige Consumer Healthcare

Prestige Consumer Healthcare

Pharmaceuticals
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

$2.3B

Market Cap • 9/22/2026

1996

(30 years)

Founded

2005

(21 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

1,2

P/S

2

P/EBITDA

7

P/OCF

9,1

P/FCF

9,6

P/E

13,4

BVPS

39,8

EPS

3,6

Market Cap

Market Cap

2,3B

EV

4,2B

EV/Revenue

3,8

EV/EBITDA

13,1

EV/EBIT

14,6

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

5,5%

Total Yield

5,5%

Payout

0%

Retained Earnings

1,8B

Profitability

Gross Margin

53,5%

EBITDA Margin

29,2%

EBIT Margin

26,3%

Net Margin

15,6%

D&A/EBITDA

6,7%

R&D/Revenue

0%

Capex/Revenue

1,3%

Capex/D&A

43,4%

Capex/OCF

5,6%

SBC/OCF

4,5%

% PPE

3,6%

% Goodwill

14,2%

ROE

9,1%

ROIC

5,3%

Growth

CAGR Revenue 5Y

2,4%

CAGR Op. Income 5Y

-1,2%

CAGR Net Income 5Y

-0,8%

CAGR EPS 5Y

0,2%

CAGR OCF 5Y

1,7%

Leverage

N.D./EBITDA

6,1

Debt/Equity

0%

Current Ratio

3,2

Quick Ratio

1,8

Interest Coverage

629,7%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium